Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

GoodRx Shares Tumble As FY22 Guidance Hit By Grocery Chain Prescription Dispute

GoodRx Holdings Inc (NASDAQ: GDRX) shares fell after it expects FY22 revenue to take a hit due to recent actions by one grocery store chain that represents a sizable chunk of its grocery prescription business.

CEVA Clocks 35% Revenue Growth In Q1 Powered By Dominance In Wireless IP

CEVA Clocks 35% Revenue Growth In Q1 Powered By Dominance In Wireless IP

CEVA, Inc (NASDAQ:CEVA) reported first-quarter FY22 revenue growth of 35% year-on-year to $34.4 million, beating the consensus of $32.9 million. Segments: Licensing, non-recurring engineering (NRE), and related revenue increased 56% Y/Y to $22.4 million. Royalty revenue rose 9% Y/Y to $12 million. The quarter saw 14 license agreements, including 3 with first-time customers. Non-GAAP…

Earnings Outlook For ADMA Biologics

Earnings Outlook For ADMA Biologics

ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that ADMA Biologics will report an earnings per share (EPS) of $-0.08.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Onconova Therapeutics Earnings Preview

Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Onconova Therapeutics will report an earnings per share (EPS) of $-0.19.

A Preview Of TRACON Pharmaceuticals's Earnings

TRACON Pharmaceuticals (NASDAQ:TCON) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that TRACON Pharmaceuticals will report an earnings per share (EPS) of $-0.42.

Earnings Preview For BioCardia

BioCardia (NASDAQ:BCDA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that BioCardia will report an earnings per share (EPS) of $-0.24.

Analyst Ratings for Rover Group

Analysts have provided the following ratings for Rover Group (NASDAQ:ROVR) within the last quarter:

inkl

Read news from The Economist, FT, and more,
with one subscription

Yield10 Bioscience Earnings Preview

Yield10 Bioscience Earnings Preview

Yield10 Bioscience (NASDAQ:YTEN) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Yield10 Bioscience will report an earnings per share (EPS) of $-0.65.

ACV Auctions's Earnings Outlook

ACV Auctions's Earnings Outlook

ACV Auctions (NASDAQ:ACVA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that ACV Auctions will report an earnings per share (EPS) of $-0.16.

Analyst Ratings for bluebird bio

Analyst Ratings for bluebird bio

Over the past 3 months, 6 analysts have published their opinion on bluebird bio (NASDAQ:BLUE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

A Preview Of icad's Earnings

A Preview Of icad's Earnings

icad (NASDAQ:ICAD) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that icad will report an earnings per share (EPS) of $-0.12.

Xeris Pharmaceuticals's Earnings Outlook

Xeris Pharmaceuticals's Earnings Outlook

Xeris Pharmaceuticals (NASDAQ:XERS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Xeris Pharmaceuticals will report an earnings per share (EPS) of $-0.25.

Why Moderna Shares Are Trading Lower Following Novavax's Earnings Report

Why Moderna Shares Are Trading Lower Following Novavax's Earnings Report

Moderna Inc (NASDAQ: MRNA) shares are trading lower by 3.15% at $131.52.

Looking Into Lucid Gr's Recent Short Interest

Looking Into Lucid Gr's Recent Short Interest

Lucid Gr's (NASDAQ:LCID) short percent of float has risen 3.74% since its last report. The company recently reported that it has 111.08 million shares sold short, which is 20.8% of all regular shares that are available for trading.

Get all your
news in one place.

100's of premium titles.
One news app.

Where Zynga Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on Zynga (NASDAQ:ZNGA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

So What's Going On With Affirm Shares Today?

Affirm Holdings Inc (NASDAQ: AFRM) shares are trading lower by 16.66% at $17.16.

Exela Shares Plunge Post Q1 Miss

Exela Technologies, Inc (NASDAQ:XELA) reported a preliminary first-quarter FY22 revenue decline of 6.9% year-on-year to $279.4 million, missing the consensus of $284.9 million. Segments: Revenue for the Information and Transaction Processing Solutions segment declined 11.6% Y/Y to $205 million due to the impact from COVID, transition revenue, staffing shortage, and currency changes. Healthcare Solutions'…

5 Value Stocks In The Consumer Cyclical Sector

What are Value Stocks?

Get all your
news in one place.

100's of premium titles.
One news app.

5 Value Stocks In The Technology Sector

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Recap: Cellectar Biosciences Q1 Earnings

Cellectar Biosciences (NASDAQ:CLRB) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Cellectar Biosciences reported in-line EPS of $-0.1 versus an estimate of $-0.1.

Check Out What Whales Are Doing With GOOGL

Someone with a lot of money to spend has taken a bearish stance on Alphabet (NASDAQ:GOOGL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Telos Registers 10% Revenue Decline In Q1; Reaffirms FY22 Guidance

Telos Corp (NASDAQ:TLS) reported a first-quarter FY22 revenue decline of 10% year-on-year to $50.2 million. Services revenue declined 7.6% Y/Y to $48.1 million. The gross margin expanded by 1,160 bps to 37.6%. Adjusted EPS loss was $(0.01). Telos generated $0.25 million in operating cash flow in the quarter and held $120.2 million in…

So What's Going On With SoFi Technologies Shares Today?

SoFi Technologies Inc (NASDAQ: SOFI) shares are trading lower by 10.05% at $5.37.

Pieris Pharmaceuticals's Earnings Outlook

Pieris Pharmaceuticals (NASDAQ:PIRS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Pieris Pharmaceuticals will report an earnings per share (EPS) of $-0.11.

Expert Ratings for EverCommerce

EverCommerce (NASDAQ:EVCM) has observed the following analyst ratings within the last quarter:

1 … 529 530 531 532

Organisations

Western Digital

SoFi Technologies Inc

Affirm Holdings

Affirm Holdings Inc

National Security Agency

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

National Security

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play